13276-52-3Relevant articles and documents
Synthesis of 2,6-dihalogenated purine nucleosides by thermostable nucleoside phosphorylases
Zhou, Xinrui,Szeker, Kathleen,Jiao, Lin-Yu,Oestreich, Martin,Mikhailopulo, Igor A.,Neubauer, Peter
, p. 1237 - 1244 (2015)
The enzymatic transglycosylation of 2,6-dichloropurine (26DCP) and 6-chloro-2-fluoropurine (6C2FP) with uridine, thymidine and 1-(β-D-arabinofuranosyl)-uracil as the pentofuranose donors and recombinant thermostable nucleoside phosphorylases from G. thermoglucosidasius or T. thermophilus as biocatalysts was studied. Selection of 26DCP and 6C2FP as substrates is determined by their higher solubility in aqueous buffer solutions compared to most natural and modified purines and, furthermore, synthesized nucleosides are valuable precursors for the preparation of a large number of biologically important nucleosides. The substrate activity of 26DCP and 6C2FP in the synthesis of their ribo- and 2′-deoxyribo-nucleosides was closely similar to that of related 2-amino- (DAP), 2-chloro- and 2-fluoroadenines; the efficiency of the synthesis of β-D-arabinofuranosides of 26DCP and 6C2FP was lower vs. that of DAP under similar reaction conditions. For a convenient and easier recovery of the biocatalysts, the thermostable enzymes were immobilized on MagReSyn epoxide beads and the biocatalyst showed high catalytic efficiency in a number of reactions. As an example, 6-chloro-2-fluoro-(β-D-ribofuranosyl)-purine (9), a precursor of various antiviral and antitumour drugs, was synthesized by the immobilized enzymes at 60°C under high substrate concentrations (uridine:purine ratio of 2:1, mol). The synthesis was successfully scaled-up [uridine (2.5 mmol), base (1.25 mmol); reaction mixture 50 mL] to afford 9 in 60% yield. The reaction reveals the great practical potential of this enzymatic method for the efficient production of modified purine nucleosides of pharmaceutical interest.
Intermediate for synthesizing 2-chloroadenosine, synthesis process of intermediate and synthesis process of 2-chloroadenosine
-
, (2021/01/25)
The invention relates to the technical field of organic synthesis, in particular to an intermediate for synthesizing 2-chloroadenosine, a synthesis process of the intermediate and a synthesis processof the 2-chloroadenosine. The synthesis process of the intermediate for synthesizing the 2-chloroadenosine comprises the following step: carrying out condensation reaction on 2,6-dichloropurine and tetraacetylribose under the catalytic action of 4-dimethylaminopyridine to form 2,3,5-4-triacetyl-2,6-dichloropurine riboside. The synthesis process is simple to operate, low in catalyst dosage, low incost, low in pollution and easy to industrially implement, and the yield and purity of the synthesized 2-chloroadenosine are higher.
A acyl-removing and protect the 2, 6 - position halogenated purine nucleoside method (by machine translation)
-
Paragraph 0019; 0020; 0021; 0022, (2018/01/13)
Invention discloses a deacylated and protect the 2, 6 - position halogenated purine nucleoside. In order to acetyl or benzoyl protection of 2, 6 - position halogenated purine nucleoside as raw materials, using acetyl chloride/alcohol system carries acetyl or benzoyl to obtain 2, 6 - position halogenated purine nucleoside, the method avoids the conventional method liquid ammonia/methanol or hydrochloric acid/methanol system, halogen atoms are amino or alkoxy substituted by-product, after treatment is simple, and high product purity, is suitable for industrial scale production. (by machine translation)